Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lipoproteins | 3 | 2024 | 871 | 1.280 |
Why?
|
| Dyslipidemias | 3 | 2024 | 872 | 1.020 |
Why?
|
| Metabolomics | 7 | 2024 | 1674 | 0.900 |
Why?
|
| Saliva | 2 | 2024 | 852 | 0.810 |
Why?
|
| Food Labeling | 1 | 2024 | 181 | 0.750 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2021 | 326 | 0.740 |
Why?
|
| Cholesterol, HDL | 3 | 2022 | 1814 | 0.700 |
Why?
|
| Triglycerides | 3 | 2022 | 2441 | 0.650 |
Why?
|
| Diabetes Mellitus, Type 2 | 10 | 2024 | 12246 | 0.600 |
Why?
|
| Prediabetic State | 1 | 2024 | 547 | 0.600 |
Why?
|
| Specimen Handling | 1 | 2022 | 706 | 0.570 |
Why?
|
| Diet, Mediterranean | 1 | 2023 | 746 | 0.520 |
Why?
|
| Proteomics | 2 | 2023 | 3915 | 0.380 |
Why?
|
| Disease Progression | 2 | 2024 | 13642 | 0.340 |
Why?
|
| Insulin Resistance | 1 | 2024 | 3989 | 0.340 |
Why?
|
| Puerto Rico | 3 | 2024 | 380 | 0.310 |
Why?
|
| Longevity | 2 | 2024 | 1083 | 0.250 |
Why?
|
| Longitudinal Studies | 6 | 2024 | 14762 | 0.240 |
Why?
|
| Amino Acids, Aromatic | 1 | 2024 | 36 | 0.230 |
Why?
|
| Meglutol | 1 | 2024 | 5 | 0.230 |
Why?
|
| Soy Foods | 1 | 2024 | 44 | 0.220 |
Why?
|
| Methylamines | 1 | 2024 | 136 | 0.210 |
Why?
|
| Heme | 1 | 2024 | 316 | 0.200 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2024 | 267 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 16044 | 0.190 |
Why?
|
| Cholesterol, LDL | 2 | 2022 | 2392 | 0.190 |
Why?
|
| Apolipoproteins B | 1 | 2022 | 385 | 0.180 |
Why?
|
| Periodontal Diseases | 1 | 2024 | 453 | 0.180 |
Why?
|
| Apolipoproteins | 1 | 2022 | 328 | 0.170 |
Why?
|
| Sweetening Agents | 2 | 2024 | 291 | 0.170 |
Why?
|
| Epidemiologic Studies | 1 | 2022 | 677 | 0.160 |
Why?
|
| Particle Size | 1 | 2022 | 1633 | 0.150 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 21162 | 0.150 |
Why?
|
| Beverages | 2 | 2024 | 819 | 0.140 |
Why?
|
| Prospective Studies | 6 | 2024 | 54872 | 0.140 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 1365 | 0.130 |
Why?
|
| Isoflavones | 1 | 2017 | 139 | 0.130 |
Why?
|
| Fructose | 1 | 2018 | 284 | 0.130 |
Why?
|
| Diet | 3 | 2023 | 8088 | 0.110 |
Why?
|
| Registries | 2 | 2023 | 8352 | 0.110 |
Why?
|
| Humans | 24 | 2024 | 766812 | 0.110 |
Why?
|
| Female | 14 | 2024 | 396532 | 0.110 |
Why?
|
| Cholesterol | 1 | 2022 | 2904 | 0.110 |
Why?
|
| Adult | 10 | 2024 | 223305 | 0.100 |
Why?
|
| Male | 12 | 2024 | 364154 | 0.100 |
Why?
|
| Nurses | 1 | 2021 | 2503 | 0.100 |
Why?
|
| Fibroblast Growth Factors | 1 | 2017 | 871 | 0.100 |
Why?
|
| Fasting | 1 | 2017 | 1609 | 0.090 |
Why?
|
| Risk Factors | 6 | 2024 | 74889 | 0.090 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 26309 | 0.080 |
Why?
|
| Cohort Studies | 5 | 2024 | 41706 | 0.080 |
Why?
|
| Incidence | 3 | 2024 | 21527 | 0.080 |
Why?
|
| Middle Aged | 8 | 2024 | 223267 | 0.080 |
Why?
|
| Atherosclerosis | 1 | 2024 | 3421 | 0.080 |
Why?
|
| Cardiovascular Diseases | 2 | 2024 | 15652 | 0.070 |
Why?
|
| Blood Glucose | 2 | 2024 | 6422 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2023 | 20146 | 0.070 |
Why?
|
| Obesity | 3 | 2024 | 13090 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2024 | 39312 | 0.070 |
Why?
|
| Massachusetts | 1 | 2020 | 8890 | 0.070 |
Why?
|
| Cause of Death | 1 | 2017 | 3717 | 0.070 |
Why?
|
| Betaine | 1 | 2024 | 90 | 0.060 |
Why?
|
| Indonesia | 1 | 2024 | 131 | 0.060 |
Why?
|
| Iron, Dietary | 1 | 2024 | 148 | 0.050 |
Why?
|
| Riboflavin | 1 | 2023 | 106 | 0.050 |
Why?
|
| Nucleosides | 1 | 2023 | 130 | 0.050 |
Why?
|
| Insulin | 1 | 2017 | 6608 | 0.050 |
Why?
|
| Carnitine | 1 | 2024 | 253 | 0.050 |
Why?
|
| Choline | 1 | 2024 | 511 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2024 | 387 | 0.050 |
Why?
|
| Boston | 2 | 2024 | 9346 | 0.050 |
Why?
|
| Glutamates | 1 | 2021 | 384 | 0.040 |
Why?
|
| Aged | 4 | 2024 | 171344 | 0.040 |
Why?
|
| Glucose | 2 | 2024 | 4340 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 24299 | 0.040 |
Why?
|
| Obesity, Abdominal | 1 | 2021 | 372 | 0.040 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2018 | 61 | 0.040 |
Why?
|
| Time Factors | 1 | 2020 | 40149 | 0.040 |
Why?
|
| Amino Acids | 1 | 2023 | 1711 | 0.040 |
Why?
|
| Eating | 1 | 2023 | 1539 | 0.030 |
Why?
|
| Folic Acid | 1 | 2023 | 1337 | 0.030 |
Why?
|
| Iron | 1 | 2024 | 1812 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2023 | 1621 | 0.030 |
Why?
|
| Overweight | 1 | 2024 | 2447 | 0.030 |
Why?
|
| Lipids | 1 | 2023 | 3322 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2017 | 1159 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2023 | 3429 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2017 | 2252 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 59548 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2662 | 0.020 |
Why?
|
| Adiposity | 1 | 2018 | 1892 | 0.020 |
Why?
|
| Prevalence | 1 | 2024 | 15835 | 0.020 |
Why?
|
| Survivors | 1 | 2017 | 2379 | 0.020 |
Why?
|
| United States | 2 | 2024 | 72945 | 0.020 |
Why?
|
| Mortality | 1 | 2017 | 2908 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2021 | 22248 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 12536 | 0.010 |
Why?
|
| Liver | 1 | 2018 | 7571 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9528 | 0.010 |
Why?
|
| Hypertension | 1 | 2018 | 8616 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 168939 | 0.000 |
Why?
|
Concepts
(101)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(44)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_